Cargando…
MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133(+) hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway
Drug resistance is still a major obstacle for efficient treatment of hepatocellular carcinoma (HCC) during the cisplatin-based chemotherapy. Recent studies have demonstrated that CD133 positive population of cancer cells are responsible for multiple drug resistance. We are supposed to take strategie...
Autores principales: | Xu, Yunxiuxiu, Lai, Yu, Weng, Hanqin, Tan, Lanping, Li, Yanshan, Chen, Guangcheng, Luo, Xingxi, Ye, Yibiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535064/ https://www.ncbi.nlm.nih.gov/pubmed/31056532 http://dx.doi.org/10.18632/aging.101876 |
Ejemplares similares
-
circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324
por: Weng, Hanqin, et al.
Publicado: (2021) -
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020) -
Effect of lincRNA-p21 targeting HIF-1α on biological functions of liver cancer cells
por: Ye, Yibiao, et al.
Publicado: (2019) -
Expression of Notch–Hif-1α signaling pathway in liver regeneration of rats
por: Li, Yanshan, et al.
Publicado: (2020) -
ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)